Upon completion of this module, the pharmacy technician should be able to do the following.
The DEA regulates controlled substances at a national level. Each state
also regulates controlled substances through state boards of pharmacy or another state agency.
If regulations governing Scheduled drugs in your state differ from the federal regulations, follow the stricter regulations.
Controlled substances are classified by federal law into five Schedules. The following Schedules are referred to in one of two ways.
Schedule I (C-I) drugs have a high potential for abuse, have no currently accepted medical use in the U.S., and are unsafe for use under medical supervision. These products are not found in pharmacy departments.
Schedule II (C-II) medications have a currently accepted medical use in the U.S. and a high potential for abuse and physical or psychological dependence.
Schedule III (C-III) medications have an abuse potential less than that of the medications listed in Schedules I and II. Abuse of these medications can lead to moderate or low physical dependence or high psychological dependence.
Schedule IV (C-IV) medications have less potential for abuse than Schedule I, II, or III medications. Abuse of these medications may lead to only a limited physical or psychological dependence.
Schedule V (C-V) medications have low potential for abuse and limited physical or psychological dependence. Schedule V drugs are any compound, mixture, or preparation containing a limited amount of a controlled substance in combination with noncontrolled active ingredients. These products are generally used as cough suppressants or antidiarrheals.
The following table summarizes dispensing regulations for Scheduled and noncontrolled substances. Details will be covered in later lessons of this module.
Refills |
Partial refills |
Storage |
Prescription needed |
Stocked |
|
Schedule I (C-I) |
– |
– |
– |
– |
No |
Schedule II (C-II) |
None |
Remainder must be dispensed within 72 hours or prescription is void. |
Locked safe |
Yes |
Yes |
Schedule III (C-III) |
No more than 5 times (or 6 months from date the prescription was written if indicated on the original prescription) |
Remainder must be dispensed before prescription expires if refills were indicated on the original prescription. |
Regular stock |
Yes |
Yes |
Schedule IV (C-IV) |
No more than 5 times (or 6 months from the date the prescription was written if indicated on the original prescription) |
Remainder must be dispensed before prescription expires if refills were indicated on the original prescription. |
Regular stock |
Yes |
Yes |
Schedule V (C-V) |
Varies by state and medication2 |
Remainder must be dispensed before prescription expires if refills were indicated on the original prescription. |
Regular stock |
No3 |
Yes |
Noncontrolled legend prescriptions4 |
As indicated on original prescription and varies by state (Generally, prescriptions written with refills as needed are valid for 1 year from date the prescription was written.) |
Remainder must be dispensed before prescription expires. |
Regular stock |
Yes |
Yes |
Listed below are common controlled substances and their respective Schedules that the pharmacy technician should be familiar with.
Schedules |
Common controlled substances |
Schedule I |
|
Schedule II |
|
Schedule III |
|
Schedule IV |
|
Schedule V |
|
Whereas the DEA regulates controlled substances on a national level, each state has its own regulations governing dispensing of drugs that are classified according to their level of abuse potential. Controlled substances are divided into five categories based on their potential for abuse.
For each of these categories, there are stipulations on the number of refills, storage and transfer, and how prescriptions are accepted. The higher the category, the stricter the requirements for dispensing and a written prescription is required for each refill. It is vital the pharmacy technician recognizes each category and the medications that fall under it.
In addition to classifying controlled substances and medications, the DEA and each state board also regulate how controlled substances and medications are dispensed.
The Controlled Substance Act requires the following statement be placed on
the container for all prescribed controlled substances: “Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed.” This warning statement makes it illegal for an individual
to give another individual any of their controlled substance medication. This statement may be on an auxiliary label similar to the one shown here. Sometimes it is preprinted on the prescription label.
Schedule I substances are never stocked in pharmacies. It is illegal in the U.S. to possess these substances. Marijuana is classified as a Schedule I controlled substance by the DEA. However, many states have legalized medical marijuana and several have legalized marijuana for recreational use. In those states where medical marijuana has been legalized, a physician is not permitted by law to prescribe it, but rather they may recommend it to the patient. Medical marijuana is purchased in a dispensary, not a pharmacy.
Prescriptions for Schedule II medications are highly regulated. Schedule II medications are only dispensed on written prescriptions personally signed by the prescribers or electronically prescribed where allowed. They must contain the full name and address of the patient, the date of issue, and the medication information.
At the federal level, the DEA permits, but does not require, a prescriber to send a prescription for a Schedule II medication electronically to the pharmacy. Additionally, federal law allows a fax to serve as the original written prescription for long-term care residents or for hospice patients.
Most states provide further specification as to how Schedule II prescriptions may be written and transmitted to pharmacies. In most states, these prescriptions must be on physical paper and personally signed by the physician. In others, they must be submitted electronically. Some states do not allow prescriptions for Schedule II drugs to be faxed. Others allow Schedule II prescriptions for parenteral use by a home infusion pharmacy to be faxed. Ask your pharmacist supervisor about the specific regulations of your state.
Some states have additional regulations such as writing the quantity in words as well as numbers, making duplicate or triplicate copies of the prescription, and limiting the time during which the prescription may be dispensed. In the case of duplicate and triplicate forms, a copy of each Schedule II prescription must be sent to the appropriate state or government agency, usually each month. When the prescription has been dispensed, the pharmacist usually cancels the prescription form by drawing a line across its face, dating, and signing or initialing the prescription form.
Depending on your state’s policy, you may need to confirm the patient’s identity when dispensing Schedule II drugs. Ask to see a driver’s license or ask the patient to sign the prescription form. Some pharmacy department policies require pharmacists to call prescribers to confirm orders for Schedule II drugs.
Sometimes, only a limited amount of a Schedule II medication may be dispensed to patients. For example, some states only allow a 1-month supply to be dispensed. Check with a pharmacist about your state’s rules and regulations.
The Comprehensive Addiction and Recovery Act (CARA) was signed into federal law in 2016 in response to the growing opioid epidemic in the United States. To support a targeted approach to dealing with the opioid crisis, CARA covers six key areas including prevention, treatment, recovery, law enforcement, criminal justice reform, and overdose reversal. CARA has numerous provisions including the launch of an evidence-based opioid treatment best practices, expansion of access to opioid overdose reversal medications, increases in educational efforts for the prevention of substance use disorder and to promote treatment options, and expansion of medication disposal sites. The provisions of CARA depend on individual states passing similar language.
Schedule II medications may not be refilled under any circumstances. If a patient requires more medication, the prescriber must write a new prescription.
Because pharmacy departments may stock only small amounts of Schedule II medications, you may only be able to partially fill these prescriptions. If this happens, a pharmacist must note the partial quantity dispensed on the face of the prescription order. A new supply of the medication must be ordered, and the remainder of the prescription must be filled within 72 hours of the partial filling. CARA permits partial fills, so long as the balance of the prescription is not filled past 30 days after the date of the original prescription.
Pharmacists may also transfer the required quantity from another pharmacy using a government-issued Schedule II DEA order form (DEA Form 222), provided that the appropriate recordkeeping is completed. If your pharmacy fails to fill the balance of the prescription within the time limit (72 hours), a pharmacist must call the prescriber to request a new prescription. Federal regulations allow exceptions to these restrictions for patients in a long-term care facility or for patients who have a terminal illness. Check with your pharmacist supervisor about the requirements for partial filling of Schedule II medications.
In some states, prescriptions for Schedule II medications may be phoned in by prescribers in an emergency. Verbal prescriptions for Schedule II medications can only be received by a pharmacist, and it is the pharmacist’s responsibility to ensure that phoned-in prescriptions are legitimate.
In such cases, only the amount needed to treat the patient during the emergency may be dispensed. Prescribers are required to furnish the pharmacy with a written, signed prescription order for the emergency dispensing within 7 days. However, some states may have more stringent regulations involving emergency prescriptions for these medications. Check with your pharmacist about the requirements in your state.
Federal regulations require Schedule II medications be stored so they are difficult to divert. There are many ways to do this, and acceptable methods of storage differ from state to state. The most secure method is to keep Schedule II drugs in a locked safe. A locked cabinet is also acceptable in some states. Many states allow pharmacy departments to dispense Schedule II medications with their regular stock. Check with a pharmacist about your pharmacy department’s method of complying with the law.
All Schedule II medication orders and invoices must be maintained separately. Any order for a Schedule II medication must be placed on a DEA Form 222 or electronically using the DEA’s Controlled Substance Ordering System. All transfers of Schedule II drugs between pharmacy departments must be recorded on this form. These medication records are kept separately so they can be tracked easily.
A pharmacy will have only one individual designated with a power of attorney to order Schedule II medications. Usually, it is the designated pharmacist in charge of the pharmacy. Typically, the pharmacist will fill out, sign, and date the form on the day the pharmacy department places the order. When the Schedule II order arrives, the pharmacist will check that the quantity and amounts ordered match those received, and log them on the order form.
Some states require a perpetual (constant) inventory of Schedule II medications. Many pharmacy departments choose to keep a perpetual inventory, even when not required by law. This running inventory record immediately informs pharmacists if controlled substances are missing or unaccounted for. The perpetual inventory shows when Schedule II medications are added to stock, when and how much medication is removed from stock bottles to fill prescriptions, and the amount of product remaining in the stock bottles. Often, the pharmacy computer is used to automatically calculate these transactions.
Most state boards of pharmacy require all pharmacies that dispense controlled substances to participate in prescription drug monitoring programs. These programs require the pharmacy to report all controlled substances dispensed during the month. The programs are also used to review medication information prior to prescribing and dispensing to a patient. Information collected on patients includes the number of controlled substance prescriptions written, the number of providers used, and the number of pharmacies used. Together these can identify potential drug-seeking or substance use disorder issues in a patient.
DEA rules and regulations require a separate, manual inventory be conducted every 2 years to track all controlled substances. Federal law requires a manual inventory of all controlled substances be conducted when there is a change in the pharmacist in charge of the pharmacy. Inventories can also be taken more often than required by law.
Written, faxed (if allowed by your state), verbal, and electronic prescription orders are permissible for Schedule III, IV, and V medications. Prescriptions for these substances may be refilled up to five times within 6 months after the prescription’s date of issue, if authorized by the prescriber.
Whenever a prescription is not required for the sale of a Schedule V medication, such as an exempt narcotic, the purchaser and the dispenser must sign the Schedule V records log. The following information must be provided in a bound Schedule V records log.
Some of the regulations regarding the dispensing of Schedule V medications are as follows.
Some states do not allow the sale of Schedule V medications without a prescription. In these states, patients have to present a prescription to obtain the medication.
Pseudoephedrine policy
The Combat Methamphetamine Epidemic Act of 2005 classified pseudoephedrine, ephedrine, and phenylpropanolamine as Scheduled Listed Chemical Product (SLCPs). Medications containing these products are subject to sales restrictions, storage requirements, and recordkeeping requirements. The federal law only applies to over-the-counter products, not prescription medications. If your state has requirements that are stricter than the federal act, the stronger requirements take precedence. Be sure to ask your pharmacist supervisor about the requirements in your state.
The law creates a sales limit of 3.6 g per day and 9 g per month to a single patient. A mobile seller is a person who makes sales at a stand that is intended to be temporary, such as a kiosk. These mobile sellers are allowed to sell 7.5 g per month per customer. The law also requires pharmacies to maintain a records log. This log must contain the product name, quantity sold, names and addresses of the purchasers, and dates and times of the sales. The purchaser must present a photo ID prior to all sales.
Maintaining a records log may not be necessary if a patient purchases a product with a very small amount of an SLCP included. Each pharmacy selling SLCPs must be self-certified each year through the DEA’s Diversion website. Documentation from the self-certification must be maintained at the pharmacy.
If your pharmacy department does not have enough of a Schedule III, IV, or V medication in stock to completely fill a prescription, you may partially fill the order according to the following guidelines.
In some cases, pharmacists may transfer a Schedule III, IV, or V prescription from one pharmacy to another. A controlled substance prescription may be transferred only one time by the pharmacy receiving the original prescription. After transferring the prescription, the receiving pharmacy is not permitted by law to transfer it to another pharmacy. Some state boards of pharmacy permit a pharmacy technician to transfer a prescription. Therefore, the pharmacy technician must be familiar with their state’s regulations. When in doubt, ask the pharmacist.
For all transferred prescriptions, there are several steps a pharmacist must take as outlined by the DEA. The pharmacist must write the word VOID on the face of the original prescription that is being transferred. On the reverse of the transferred prescription, the following information must be noted.
All of this information must be added to the prescription record in the case of electronic prescriptions. After the prescription has been transferred to another pharmacy department, the pharmacist will make a note in the computer that the prescription has been transferred.
The word TRANSFER must be written on the prescription by the pharmacist receiving the transferred prescription. This applies to all prescriptions. The following information should be included on the prescription by the receiving pharmacist.
Some states require the pharmacy to receive new prescriptions from physicians and do not allow dispensing from a copy of a prescription transferred from another pharmacy.
When transferring a prescription electronically, the transferring pharmacist must provide the receiving pharmacist with the following information in addition to the original electronic prescription data.
The pharmacist receiving a transferred electronic prescription must create an electronic record with the receiving pharmacist’s name and all the information transferred with the prescription (listed above). The original and transferred prescription(s) must be maintained for a period of 2 years from the date of last refill.
If the transfer involves a Schedule II medication being transferred to another pharmacy in need of the medication, the official DEA Form 222 must be completed. This form is completed in triplicate. One copy is sent to the DEA, one copy is retained by the supplier, and one copy is retained by the receiver.
Controlled substance dispensing regulations set forth by the DEA and state boards vary by drug Schedule. These regulations affect refills, partial fills, storage, inventory, and ordering. Given the pharmacy technician’s central role in processing prescriptions and managing inventory, and because dispensing regulations vary from state to state, it is essential that the technician fully understand both their state and federal regulations to support appropriate medication management and compliance with the law. If the state regulations differ from federal laws, the technician should always follow the stricter regulations.
Because Schedule II medications have the highest potential for abuse among Scheduled medications that are legal to dispense, they have the strictest regulations. Below are some examples of regulations that are unique to Schedule II medications.
Schedule III and IV prescriptions have fewer restrictions, and in some states, Schedule V medications do not require a prescription. Schedule III, IV, and V medications may be transferred to another pharmacy following specific regulations set forth by both the DEA and the state.
Well-organized prescription files not only make verifying prescription information easy, but also prepare you for audits. Your pharmacy department files could be inspected by a representative of the state board of pharmacy or by the DEA. The DEA focuses its attention on records for controlled substances. Making sure prescriptions for controlled substances meet all DEA requirements requires an understanding of DEA numbers and DEA regulations. Records must also be kept when any controlled substances must be destroyed.
In addition to the standard information required for any prescription, prescription forms for controlled substances require the prescriber’s DEA number. The forms must contain the prescriber’s full name, complete address (street number, street name, suite number, city, state, and ZIP code) and DEA number. The forms must also contain the patient’s full name and complete address.
Counterfeit DEA numbers on forged prescriptions can be detected using the formula that the DEA created to generate DEA numbers. DEA numbers are composed of two letters followed by seven digits.
The first letter indicates the type of registrant.
The second letter in the DEA number matches the first letter of the prescriber’s last name. There are some exceptions. For example, a physician who changes their last name may retain an old DEA number.
The seven digits provide a means of numerically validating the DEA number. This is done by adding the first, third, and fifth digits. Next, add the second, fourth, and sixth digits, and multiply the sum by two. Finally, add the results of the first two steps. The last digit of this sum should be the same as the seventh digit of the DEA number.
Dr. Smith has the DEA number AS4967432 |
|
AS4967432 |
The first letter A meets the condition that the first letter must be an A, B, F, M or X. |
AS4967432 |
The second letter S is the first letter of the last name Smith. |
AS4967432 |
The sum of the first, third, and fifth numbers is: 4 + 6 + 4 = 14. |
AS4967432 |
The product of the sum of the second, fourth, and sixth numbers is: 9 + 7 + 3 = 19. And 19 × 2 = 38. |
AS4967432 |
The sum of the previous results is 14 + 38 = 52. The last digit matches the last digit of the DEA number, which means the number is legitimate. |
A practitioner (intern, resident, staff physician, or midlevel practitioner) working in a hospital may use the hospital’s DEA number followed by an internal code issued by the hospital.
After a prescription has been filled and checked by the pharmacist, the pharmacy technician may be asked to file the filled prescription. A pharmacy technician must be familiar with how the pharmacy files prescriptions to ensure they are readily retrievable.
Federal regulations allow two options for filing paper prescription records. Both require documenting medications dispensed in separate files based on Schedule.
The first option requires the maintenance of three files: all Schedule II medications; all Schedule III, IV, and, V medications; and all noncontrolled medications.
The second option requires two files: all Schedule II medications and all other medications (Schedule III, IV, V, and noncontrolled medications). Prescriptions for Schedule III, IV, and V medications should be made readily retrievable by marking them with a red C stamp, not less than 1 inch high.
Pharmacies that use electronic prescription processing must retain all associated records electronically. These records should be maintained for at least 2 years. For electronic recordkeeping systems, a red C stamp is not necessary. However, all Scheduled prescriptions should be readily retrievable and readable.
The destruction of controlled substances is most often completed by a reverse distributor. A reverse distributor is registered with the state and federal government to manage the removal and disposal of controlled substances for the pharmacy by transferring the controlled substance back to the manufacturer to facilitate disposal. If the pharmacy chooses to use a reverse distributor, a DEA Form 222 to transfer Schedule II controlled substances to the reverse distributor must be completed. A copy of the completed form should be retained at the pharmacy.
A pharmacy may want to destroy controlled substances that are expired, damaged, or unwanted. However, this should be done only if reverse distributors are unable to accept the medications for destruction. In this case, the pharmacy must complete a DEA Form 41. A pharmacy can request DEA authorization to destroy controlled substances once each year.
Because the DEA focuses its attention on controlled substances, it is crucial that all prescriptions for controlled substances meet DEA requirements, including DEA numbers. The prescriber’s information as well as the patient’s identifying information are both required on a prescription in order to dispense the medication. Fraudulent DEA numbers and prescriptions can be easily detected following the formula used to create a DEA number, two letters followed by seven digits with each letter representing a significant registrant identifier.
Federal regulations mandate how paper prescriptions are filed and are specific to the controlled substance Schedule in a file marked with a red C. Electronic prescriptions, however, must be maintained electronically for 2 years. Likewise, when destroying controlled substances, a pharmacy is required to submit the mandatory forms and transfer through a reverse distributor. Pharmacies can request permission to destroy expired or tainted medications once a year.
Audio differs from text due to recent content updates. Audio will be updated soon. The abuse of prescription medications, especially controlled substances, is a serious social and physical problem. As a health care professional, the pharmacy technician shares the responsibility for identifying and preventing prescription substance use disorder in patients and coworkers. The pharmacy technician must become aware of potential situations where drug diversion—the attempt to get drugs illegally—can occur and have safeguards that can help prevent this diversion.
Both DEA and state authorities consider retail-level diversion a priority issue. Missing controlled substances must be reported to the DEA and local police as soon as the loss is known. Pharmacy technicians can assist the pharmacist in collecting the necessary information.
The pharmacist will need the following information to complete a DEA Form 106.
The pharmacist will submit the DEA Form 106 online or in paper to the DEA diversion field office. A copy will be kept in the pharmacy’s records for at least 2 years.
As a pharmacy technician, you should avoid viewing patients as criminals. However, it is important to recognize the following common methods that forgers use to obtain medications illegally.
The following characteristics are commonly found in fraudulent prescriptions.
The following criteria may indicate that an alleged prescription was not issued for a legitimate medical purpose.
The following techniques will help prevent diversion of controlled substances in your pharmacy.
Federal law requires handwritten Medicaid prescriptions be on tamper-resistant prescription pads. State laws may also have specific requirements for Medicaid prescriptions. Tamper-resistant pads must have at least one feature that prevents or discloses copying, one feature that prevents or discloses erasing or modifying, and at least one feature that prevents or discloses counterfeiting. Electronic prescriptions also have tamper-resistant features. Examples of prevention or disclosure methods for each of these categories are listed below.
Feature |
Handwritten prescription examples |
Electronic prescription |
Copying |
High-security watermark revealing words (e.g., VOID, ILLEGAL, or COPY) if photocopied |
Signature line containing words (such as “original prescription”) in small letters that are illegible if copied |
Erasing or modifying |
Tamper-resistant background Quantity checkbox, in addition to writing out the quantity Refill options in which the number of refills authorized is circled |
Spelling out the numbers instead of writing the number (for example, ONE instead of 1) Including asterisks around the numbers (***3***) |
Counterfeiting |
Unique prescription identifiers such as sequentially numbered prescriptions Spelling out the numbers instead of writing the number (for example, ONE instead of 1) |
Unique prescription identifiers such as sequentially numbered prescriptions Spelling out the numbers instead of writing the number (for example ONE instead of 1) |
Some states use either duplicate or triplicate blanks (or rotate between them), which are similar to the DEA Form 222 used to order Schedule II controlled substances, to produce tamper-resistant prescription pads.
Medicaid prescriptions that do not require tamper-resistant prescription pads include the following.
As a key member of the pharmacy team and a first point of contact with patients, the pharmacy technician has a central role in preventing diversion of controlled substances. To prevent diversion, the pharmacy technician must be aware of situations in which it can occur and take precautions to reduce opportunities for diversion. Actions the pharmacy technician can take include the following.
The pharmacy technician should understand that by taking actions to identify and safeguard against controlled substance diversion, they are helping to prevent a serious social problem.
Pharmacy personnel have a responsibility to reduce substance use disorders when they are discovered in both patients and colleagues. There are times a legal and valid prescription may lead to the patient developing a substance use disorder. In light of the current opioid epidemic, it is extremely important for a pharmacy technician to recognize the symptoms of opioid abuse.
Tolerance is when a person’s body adapts to the medication, causing the medication to not work as well. Individuals experiencing tolerance may have the following symptoms.
Physical dependence is similar to tolerance in that both are normal processes in which the body adapts to a medication’s effect. However, with physical dependence symptoms occur when there is a sudden decrease in the amount of medication taken. The sudden decrease may be caused by decreasing the dose of the medication, taking other medications that interact with the current medication, or noncompliance (for example, the patient forgets to take the medication).
Some of the withdrawal symptoms seen with physical dependence include the following.
Chemical dependence, or substance use disorder, is serious. Just because an individual has medication-seeking or medication-craving behavior does not mean that they are addicted. As mentioned earlier, some individuals adapt to or tolerate the medication’s effect and still have pain. The following symptoms of chemical dependence can help differentiate whether a person has a substance use disorder or is simply tolerant to the medication.
The pharmacy technician is often the first person a patient encounters at the pharmacy. It is difficult at times to distinguish between legitimate use and intentional abuse of a medication. The medication-seeking individual may be unfamiliar to the pharmacy technician. They could claim to be from out of town and say they have lost or forgotten a prescription or medication. Recognizing characteristics in their appearance, behavior, responses, medication selection, and timing is the first step to identifying the medication-seeking patient who may be attempting to manipulate the pharmacy technician.
As a pharmacy technician you should not judge a person by their appearance. However, there are certain observable physical signs that may indicate an individual is seeking medication for a nonlegitimate medical use. Some of these signs include the following.
If you observe these signs you should bring it to the attention of the pharmacist.
The pharmacy technician should be aware of the following behaviors that may indicate an individual is seeking medication for a nonlegitimate medical use.
When talking with a patient the technician may observe the following suspicious responses by an individual seeking medication for a nonlegitimate medical use.
All concerning responses by the patient to the technician should be shared with the pharmacist.
An individual seeking medication for a nonlegitimate medical use may have the following suspicious responses regarding medications.
As a technician, you may observe the following suspicious examples of a patient’s timing in having a prescription filled.
Patients rely on the pharmacy during times when they feel their weakest. As a pharmacy technician, you have the ability to witness, document, and alert care providers to signals that a patient may have become chemically dependent on a substance. When working with a patient you suspect is attempting to gain narcotics as part of a substance use disorder, it is important to not ignore the signals.
The following are some of the actions that a pharmacy technician can take.
Coworkers with substance use disorder often exhibit similar suspicious behaviors as patients, and these should be reported to the pharmacist. Additionally, changes in attendance and punctuality, appearance, behavior, skill accuracy, and involvement with controlled substances.
If you suspect substance use disorder in a coworker, you should talk to your pharmacist, manager, or human resource department. For some employees, their supervisor talking to them about poor work performance or suspicious behaviors is enough motivation to help them change. The threat of losing a job may have more influence on a substance user than a loved one’s threat to end a relationship.
A number of state licensing boards, employee assistance programs (EAPs), state diversion programs, and peer assistance organizations will refer individuals and their families to appropriate counseling and treatment services. An EAP is work-based intervention program that assists employees who have personal problems, including substance use disorders that might have a negative impact on the employee’s work habits. These services maintain the confidentiality of those seeking assistance to the greatest extent possible. Benefits of these programs include improving an employee’s job performance, reducing employee tardiness, and improving employee morale. Many different medication treatments are used in to treat a variety of substance use disorders.
Generic name |
Brand name |
Indications |
Acamprosate |
Campral |
Alcohol dependence |
Disulfiram |
Antabuse |
Alcohol dependence |
Naltrexone |
Vivitrol |
Alcohol dependence, opioid dependence |
Buprenorphine |
Buprenex, Butrans, Probuphine, Sublocade, Belbuca |
Opioid dependence |
Buprenorphine-naloxone |
Suboxone |
Opioid dependence |
Naloxone |
Narcan |
Opioid overdose |
Bupropion |
Zyban |
Nicotine dependence |
Nicotine replacement therapy |
NicoDerm CQ, Nicorette gum, NicotrolNS |
Nicotine dependence |
Varenicline |
Chantix |
Nicotine dependence |
It is important for the pharmacy technician to recognize possible substance use disorder. Understanding the difference between tolerance and dependence will play an important part in addressing substance use disorders. Patients who have developed a tolerance for a medication might request early refills, take more medication than prescribed, and report that their condition is getting worse. A patient exhibiting tolerance does not necessarily mean they have a substance use disorder. If tolerance is suspected, notify the pharmacist. Providing early intervention can prevent physical and chemical dependence.
Physical dependence is experienced when the medication has been suddenly decreased and is manifested by signs of withdrawal such as the following.
Some signs of chemical dependence include the following.
Many signs can alert the pharmacy technician to a patient experiencing a substance use disorder including altered behavior, disheveled appearance, vague or incongruent responses, demands for specific medication selection, and demands for quick turnaround. When substance use disorder is suspected request patient identification, document encounters, and alert the pharmacy. Colleagues will exhibit the same characteristics when facing substance use disorder and might have trouble being punctual and productive. Any signs of substance use disorder in a colleague should be reported to the pharmacist or supervisor for intervention.